+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

COVID-19 Mitigation Products: Market Research, to 2024

  • ID: 5137067
  • Report
  • August 2020
  • Region: Global
  • 1020 Pages
  • Homeland Security Research Corporation
1 of 3
Cumulative 2020-2024 Market: $1.6 Trillion (scenario A); $2.2 Trillion (scenario B), 248 Sub-Markets. 5 Volumes.

FEATURED COMPANIES

  • 3M Company
  • Bollé Safety
  • Flow Health
  • Inovio Pharmaceuticals
  • Medasense
  • PhysIQ.
  • MORE

On the backdrop of the global pandemic, a need for essential pandemic mitigation products and services emerged a new market, the COVID-19 Pandemic Mitigation Products Market.

To adhere to high standards of research, as nobody can forecast the future of the pandemic, the publisher includes in the report two scenarios:

  • Optimistic scenario – assumes (among other things) that mass vaccination will commence by July 2021
  • Conservative scenario – assumes (among other things) that no mass vaccination will be available until July 2024

According to the report scenarios, the cumulative 2020-2024 market* size is expected to be $1.6 Trillion (scenario A, the optimistic one) and $2.2 Trillion (scenario B, conservative).

Why trust this report?

  • The team which created this report was led by ex-executives of the medical industry and bio-security experts
  • The team has published since 2006, 36 Pandemic related market reports
  • Team members managed since 1974 medical industry companies, sales & marketing, and R&D departments
  • As the COVID-19 pandemic knowledge changes all the time, the publisher updates the report once a month

The COVID-19 pandemic exposed acute deficiencies of many essential products and services, from PPE & ventilators to surge ICUs and homecare equipment, from PCR reagents to digital contact tracing systems. Never before has world leading healthcare communities been faced with the likelihood of having to ration or function without critical medical supplies and services on this magnitude.

The COVID-19 Mitigation Products Market Research presents a thorough market analysis of 54 products & services, 6 end user, 4 revenue source, 5 regional and 13 national markets. Furthermore, the report provides updated extensive data of 37 key vendors.

This 1035-page 5-volume market report is the first and most comprehensive review of the global COVID-19 Pandemic Mitigation Products & Services market available today. The objective of this report is to provide today’s strategic decision-makers with an expert 360-degree, time-sensitive, detailed view of this interconnected market. The report includes the industry value chain, SWOT analysis, market drives & inhibitors, business opportunities, barriers to entry, supplier power, buyer power and barriers to substitution.

COVID-19 Mitigation Products

Why Buy this report?

A. Questions answered in this report include:

  • What is the COVID-19 Pandemic Mitigation Products & Services market size and what are the forecast trends during 2020-2024?
  • What are the most attractive business opportunities?
  • What drives the customers to purchase solutions and services?
  • What are the COVID-19 Mitigation technology & services trends?
  • What is the 212 sub-markets size over the 2020-2024 period?
  • What are the challenges to market penetration & growth?

B. The COVID-19 Pandemic Mitigation Products Market size data is analyzed via 5 independent key perspectives.

With a highly fragmented market the publisher addresses the “money trail” – each dollar spent in the global COVID-19 Pandemic Mitigation market is analyzed and crosschecked via 5 orthogonal viewpoints:

By 54 Products and Services:

  • Vaccines
  • Therapeutic Drugs
  • Other COVID-19 Pharma Industry Products
  • PCR Instrumentation & Software
  • Robotic PCR Systems & Software
  • PCR Reagents & Consumables
  • Nose & Mouth Swabs
  • Self-collection PCR Test Kits
  • Serologic Test Kits
  • Standoff Thermometry
  • X-Ray Procedures
  • CT Procedures
  • Ultrasound Procedures
  • FDG-PET/CT Procedures & Wastewater Testing
  • PACS & Teleradiology
  • Medical PPE Gowns
  • Medical Gloves
  • Medical  Face Masks
  • Medical Face Shields
  • Medical Eye Protection
  • PPE Sterilization: Systems & Consumables
  • Hand & Surface Sanitizers
  • Decontamination
  • Other Personal Protection Gear
  • AI, Big Data & Deep Learning
  • Homecare IT
  • Geo-Surveillance Systems & Services
  • E-Health
  • Blockchain Technologies
  • Other ICT
  • Noninvasive Ventilators
  • Invasive Mechanical Ventilators
  • Next Generation Ventilators
  • COVID-19 Homecare (HW, SW, Services)
  • Portable Ventilators
  • Surge Capacity Hospitals & ICUs
  • Kidney Dialysis
  • Extracorporeal Membrane Oxygenation Procedures
  • Other Intensive Care Modalities
  • PPE Gowns Manufacturing Plants
  • Gloves Manufacturing Plants
  • Face Masks Manufacturing Plants
  • Face Shields Manufacturing Plants
  • Sorologic Test Kits Manufacturing Plants
  • Melt-Blown PPE Fabric Manufacturing Plants
  • Spun-Bond PPE Fabric Manufacturing Plants
  • Self-collection PCR Test Kits Manufacturing Plants
  • Ventilators Manufacturing Plants
  • PCR Reagents Manufacturing Plants
  • PCR Systems Manufacturing Plants
  • Nose & Mouth Swabs Manufacturing Plants
  • Medical Glass & Other Manufacturing Plants
  • R&D Equipment & Consumables
  • Medical Glass and Other Products & Services

By 6 End User Markets:

  • Hospitals and Surge Hospitals
  • Clinical Labs
  • Clinics
  • Emergency Medical Services (EMS)
  • Homecare & Nursing Homes
  • Research Bodies

By 13 National Markets:

  • U.S.A
  • Canada
  • UK
  • Germany
  • France
  • Italy
  • Rest of Europe
  • India
  • China
  • South Korea
  • Japan
  • Rest of Asia Pacific
  • RoW

By 5 Regional Markets:

  • North America
  • Latin America
  • Europe
  • Middle East & Africa
  • Asia Pacific

By 4 Revenue Source Markets:

  • Product Sales
  • Training Services
  • Planning & Consulting
  • Maintenance & Upgrades

C. Detailed market analysis frameworks for each of the market sectors are provided, including:

  • Market drivers & inhibitors
  • Business opportunities
  • SWOT analysis

Competitive analysis for each of the 54 products and services that covers:

  • Barriers to Entry
  • Supplier Power
  • Buyer Power
  • Barriers to Substitution.
  • Business environment
  • The 2020-2024 market segmented into 212 submarkets

D. The report provides an updated extensive data of the leading 37 companies (including companies’ profile, recent annual revenues, COVID-19 mitigation activities & products and contact information).

E. The report includes over 2300 links to the COVID-19 Pandemic Mitigation community information sources

Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • 3M Company
  • Bollé Safety
  • Flow Health
  • Inovio Pharmaceuticals
  • Medasense
  • PhysIQ.
  • MORE

5 Volumes:

  • COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 1
  • COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 2
  • COVID-19 Pandemic Mitigation products Market – 2020-2024: Volume 3
  • COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 4
  • COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 5

COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 1

1 Market Definition
1.1 Introduction
1.2 Scenario A: Assumptions
1.3 Scenario B: Assumptions

2 Executive Summary
2.1 Key Findings.
2.2 COVID-19 Mitigation Funding (January – May 2020).
2.3 Key Conclusions.
2.4 COVID-19 Pandemic Mitigation Products Market Research Vectors
2.5 COVID-19 Pandemic Mitigation R&D Challenges.
2.6 Global COVID-19 Pandemic Mitigation Market – 2020-2024
2.6.1 Products & Services Groups Markets
2.6.2 Products & Services Markets
2.6.3 Vertical Markets
2.6.4 Revenue Source Markets
2.6.5 Regional Markets
2.6.6 National Markets.

3 The SARS-CoV-2 2019 Pandemic
3.1 COVID-19 Basics
3.2 COVID-19 Infection Rate.
3.3 Social Distancing.
3.4 The Effect of Quarantine.
3.5 Comparison of SARS-CoV-2 and Common Cold and Flu Viruses
3.6 The SARS-CoV-2 Genome Information
3.7 Active Infection Testing
3.7.1 Nucleic Acid Detection.
3.7.2 Antigen Detection
3.7.3 Other Technologies
3.8 Serology Testing.

4 Market Drivers

5 Market Inhibitors.

6 COVID-19 Pandemic Mitigation Products Market SWOT Analysis
6.1 Strengths
6.2 Weaknesses.
6.3 Opportunities
6.4 Threats

7 Business Opportunities & Challenges

8 COVID-19 Pandemic Mitigation Industry
8.1 The COVID-19 Pandemic Mitigation Products Value Chain
8.2 COVID-19 Pandemic Mitigation Products Industry Primary Activities
8.3 COVID-19 Pandemic Mitigation Products industry Support Activities

9 COVID-19 Pandemic Mitigation Products Industry: Barriers to Entry, Supplier Power, Buyer Power & Barriers to Substitution.

GLOBAL MARKET

10 Global COVID-19 Pandemic Mitigation Market – 2020-2024.
10.1 Global COVID-19 Pandemic Mitigation Products & Services Groups Markets – 2020-2024.
10.1.1 Global COVID-19 Pandemic Mitigation Products & Services Groups Markets: Scenario A.
10.1.1.1 Market Size
10.1.1.2 Market Dynamics
10.1.1.3 Market Share
10.1.2 Global COVID-19 Pandemic Mitigation Products & Services Groups Markets: Scenario B.
10.1.2.1 Market Size
10.1.2.2 Market Dynamics
10.1.2.3 Market Share
10.1.3 Global COVID-19 Pandemic Mitigation Market: Scenarios Comparison
10.2 Global COVID-19 Pandemic Mitigation Products & Services Markets – 2020-2024
10.2.1 Global COVID-19 Pandemic Mitigation Products & Services Markets: Scenario A
10.2.1.1 Market Size
10.2.1.2 Market Dynamics
10.2.2 Global COVID-19 Pandemic Mitigation Products & Services Markets: Scenario B
10.2.2.1 Market Size
10.2.2.2 Market Dynamics
10.2.3 Global COVID-19 Pandemic Mitigation Products & Services Groups Markets: Scenarios Comparison
10.3 Global Vertical COVID-19 Pandemic Mitigation Markets – 2020-2024.
10.3.1 Global COVID-19 Pandemic Mitigation Vertical Markets: Scenario A.
10.3.1.1 Market Size.
10.3.1.2 Market Dynamics
10.3.1.3 Market Share
10.3.2 Global COVID-19 Pandemic Mitigation Vertical Markets: Scenario B.
10.3.2.1 Market Size.
10.3.2.2 Market Dynamics
10.3.2.3 Market Share
10.3.3 Global COVID-19 Pandemic Mitigation Vertical Markets: Scenarios Comparison
10.4 Global COVID-19 Pandemic Mitigation Products & Services Market by Revenue Source – 2020-2024
10.4.1 Global COVID-19 Pandemic Mitigation Products & Services Market: Scenario A
10.4.2 Global COVID-19 Pandemic Mitigation Products & Services Market: Scenario B
10.4.3 Global COVID-19 Pandemic Mitigation Revenue Sources: Scenarios Comparison
10.5 Regional COVID-19 Pandemic Mitigation Markets – 2020-2024.
10.5.1 Regional COVID-19 Pandemic Mitigation Market: Scenario A.
10.5.1.1 Market Size.
10.5.1.2 Market Dynamics
10.5.1.3 Market Share
10.5.2 Regional COVID-19 Pandemic Mitigation Market: Scenario B.
10.5.2.1 Market Size.
10.5.2.2 Market Dynamics
10.5.2.3 Market Share
10.5.3 Regional COVID-19 Pandemic Mitigation Market: Scenarios Comparison
10.6 National COVID-19 Pandemic Mitigation Markets – 2020-2024.
10.6.1 National COVID-19 Pandemic Mitigation Market: Scenario A.
10.6.1.1 Market Size.
10.6.1.2 Market Dynamics
10.6.1.3 Market Shares
10.6.2 National COVID-19 Pandemic Mitigation Market: Scenario B.
10.6.2.1 Market Size.
10.6.2.2 Market Dynamics
10.6.2.3 Market Share
10.6.3 COVID-19 National Markets: Scenarios Comparison

COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 2

PRODUCT/SERVICE MARKETS.

1 COVID-19 Vaccines Market – 2020-2024
1.1 COVID-19 Vaccines Market Background
1.1.1 Introduction
1.1.2 Global COVID-19 Vaccine Development Funding
1.1.3 Vaccines Prices
1.1.4 COVID-19 Vaccines Market: Conclusions
1.1.5 COVID-19 Vaccines: Business Opportunities
1.1.6 COVID-19 Vaccines: Competitive Analysis: : Barriers to Entry, Supplier Power, Buyer Power and Substitution
1.1.7 Present and Potential Vendors.
1.2 Global COVID-19 Pandemic Mitigation: Vaccines Market – 2020-2024
1.2.1 Vaccines COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
1.2.2 Vaccines COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

2 COVID-19 Post-Infection Therapeutic Drugs Market – 2020-2024
2.1 COVID-19 Post-Infection Therapies Drugs Market Background
2.1.1 Introduction
2.1.2 Computer Aided COVID-19 Drug Research
2.1.3 Adaptive Designs For COVID-19 Clinical Trials
2.1.4 COVID-19 Therapeutic Drugs Market: Conclusions.
2.1.5 COVID-19 Therapeutic Drug: Business Opportunities
2.1.6 COVID-19 Post-Infection Therapeutic Drug: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution
2.1.7 Present and Potential Vendors.
2.2 Global COVID-19 Post-Infection Therapeutic Drugs Market – 2020-2024
2.2.1 COVID-19 Post Infection Therapeutic Drugs Market – 2020-2024: Scenario A
2.2.2 Therapeutic Drugs COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

3 Other Pharma Industry Products COVID-19 Pandemic Mitigation Market – 2020-2024
3.1 Other COVID-19 Pharma Industry Products Market Background
3.1.1 Introduction and Findings
3.1.2 Other COVID-19 Pharma Industry Products Market: Conclusions.
3.1.3 Other COVID-19 Pharma Industry Products: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution
3.2 Global COVID-19 Pandemic Mitigation: Other Pharma Industry Products Market – 2020-2024.
3.2.1 Other Pharma Industry Products COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
3.2.2 Other Pharma Industry Products COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

4 PCR Instrumentation & Software COVID-19 Pandemic Mitigation Market – 2020-2024
4.1 COVID-19 PCR Instrumentation & Software Market Background
4.1.1 Introduction
4.1.2 PCR Technologies & Procedures
4.1.3 PCR Advantages
4.1.4 PCR Limitations
4.1.5 PCR Based Coronavirus Diagnostics Used and Developed During January – April 2020.
4.1.6 Efforts to Develop and Disseminate a Test for COVID-19.
4.1.7 PCR Purchasing Considerations.
4.1.8 Costs of PCR Testing
4.1.9 PCR Instrumentation & Software Market: Conclusions.
4.1.10 PCR Instrumentation & Software: Business Opportunities
4.1.11 PCR Instrumentation & Software: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution
4.1.12 Key Vendors.
4.2 Global COVID-19 Pandemic Mitigation: PCR Instrumentation & Software Market – 2020-2024.
4.2.1 PCR Instrumentation & Software COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
4.2.2 PCR Instrumentation & Software COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

5 Robotic PCR Systems & Software COVID-19 Pandemic Mitigation Market – 2020-2024
5.1 COVID-19 Robotic PCR Systems & Software Market Background
5.1.1 Introduction and Findings
5.1.2 Pooling PCR Method Testing Over 60 Samples Simultaneously
5.1.3 Robotic PCR Systems & Software Market: Conclusions
5.1.4 Robotic PCR Systems & Software: Business Opportunities.
5.1.5 Robotic PCR Systems & Software: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution
5.2 Global COVID-19 Pandemic Mitigation: Robotic PCR Systems & Software Market – 2020-2024
5.2.1 Robotic PCR Systems & Software COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
5.2.2 Robotic PCR Systems & Software COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

6 PCR Reagents & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024
6.1 COVID-19 PCR Reagents & Consumables Market Background
6.1.1 Introduction.
6.1.2 PCR Reagents & Consumables Market: Conclusions
6.1.3 PCR Reagents & Consumables: Business Opportunities.
6.1.4 PCR Reagents & Consumables: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution
6.2 1.2 Global COVID-19 Pandemic Mitigation: PCR Reagents & Consumables Market – 2020-2024
6.2.1 PCR Reagents & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
6.2.2 PCR Reagents & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

7 Nose & Mouth Swabs COVID-19 Pandemic Mitigation Market – 2020-2024
7.1 COVID-19 Nose & Mouth Swabs Market Background.
7.1.1 Introduction and Findings.
7.1.2 Nose & Mouth Swabs: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution.
7.2 Global COVID-19 Pandemic Mitigation: Nose & Mouth Swabs Market – 2020-2024
7.2.1 Nose & Mouth Swabs COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
7.2.2 Nose & Mouth Swabs COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

8 Self-collection PCR Test Kits COVID-19 Pandemic Mitigation Market – 2020-2024
8.1 COVID-19 Self-collection PCR Test Kits Market Background.
8.1.1 Saliva Tests
8.2 COVID-19 Pandemic Mitigation: Self-collection PCR Test Kits Market – 2020-2024
8.2.1 Self-collection PCR Test Kits COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
8.2.2 Self-collection PCR Test Kits COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

9 Serologic Test Kits COVID-19 Pandemic Mitigation Market – 2020-2024
9.1 COVID-19 Serologic Test Kits Market Background.
9.1.1 Introduction and Findings.
9.1.2 FDA Statement Related to the Status of Serological (Antibody) Tests
9.1.3 Coronavirus Antibody Test Kits
9.1.4 Serologic Test Kits Market: Conclusions
9.1.5 Serologic Test Kits: Business Opportunities.
9.1.6 Serologic Test Kits: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution.
9.1.7 Key Vendors
9.2 Global COVID-19 Pandemic Mitigation: Serologic Test Kits Market – 2020-2024.
9.2.1 Serologic Test Kits COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
9.2.2 Serologic Test Kits COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

10 Standoff Thermometry COVID-19 Pandemic Mitigation Market – 2020-2024
10.1 COVID-19 Standoff Thermometry Market Background.
10.1.1 Introduction and Findings.
10.1.2 Standoff Thermometry Market: Conclusions
10.1.3 Standoff Thermometry: Business Opportunities.
10.1.4 Key Vendors
10.2 Global COVID-19 Pandemic Mitigation: Standoff Thermometry Market – 2020-2024
10.2.1 Standoff Thermometry COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
10.2.2 Standoff Thermometry COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

11 X-Ray Procedures COVID-19 Pandemic Mitigation Market – 2020-2024
11.1 COVID-19 X-Ray Procedures Market Background.
11.1.1 Introduction and Findings.
11.1.2 X-Ray Procedures Market: Conclusions
11.1.3 Key Vendors
11.2 Global COVID-19 Pandemic Mitigation: X-Ray Procedures Market – 2020-2024.
11.2.1 X-Ray Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
11.2.2 X-Ray Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

12 CT Procedures COVID-19 Pandemic Mitigation Market – 2020-2024
12.1 COVID-19 CT Procedures Market Background.
12.1.1 Introduction and Findings.
12.1.2 CT Procedures Market: Conclusions.
12.1.3 CT Procedures: Business Opportunities.
12.1.4 Key Vendors
12.2 Global COVID-19 Pandemic Mitigation: CT Procedures Market – 2020-2024
12.2.1 CT Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
12.2.2 CT Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

13 Ultrasound Procedures COVID-19 Pandemic Mitigation Market – 2020-2024
13.1 COVID-19 Ultrasound Procedures Market Background.
13.1.1 Introduction and Findings.
13.1.2 FDA Approved “ EMT & Field” Smartphone-Tablet Based Coronavirus Chest Ultrasound
13.1.3 COVID-19 Chest Ultrasound Diagnostics.
13.1.4 Ultrasound Procedures Market: Conclusions
13.1.5 Ultrasound Procedures: Business Opportunities.
13.1.6 Key Vendors
13.2 Global COVID-19 Pandemic Mitigation: Ultrasound Procedures Market – 2020-2024
13.2.1 Ultrasound Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
13.2.2 Ultrasound Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

14 FDG-PET/CT Procedures & Wastewater Testing COVID-19 Pandemic Mitigation Market – 2020-2024.
14.1 COVID-19 FDG-PET/CT Procedures & Wastewater Testing Market Background.
14.1.1 Introduction and Findings.
14.1.2 FDG-PET/CT Procedures.
14.1.3 COVID-19 Wastewater Testing
14.1.4 FDG-PET/CT Procedures & Wastewater Testing Market: Conclusions
14.1.5 FDG-PET/CT Procedures & Wastewater Testing: Business Opportunities.
14.1.6 Key Vendors
14.2 Global COVID-19 Pandemic Mitigation: FDG-PET/CT Procedures & Wastewater Testing Market – 2020-2024
14.2.1 FDG-PET/CT Procedures & Wastewater Testing COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
14.2.2 FDG-PET/CT Procedures & Wastewater Testing COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

15 PACS & Teleradiology COVID-19 Pandemic Mitigation Market – 2020-2024
15.1 PACS & Teleradiology Market Background.
15.1.1 Introduction and Findings.
15.1.2 The FDA PACS & Teleradiography COVID-19 Pandemic Policy.
15.1.3 PACS & Teleradiology Market: Conclusions
15.1.4 PACS & Teleradiology: Business Opportunities.
15.1.5 Key Vendors
15.2 Global COVID-19 Pandemic Mitigation: PACS & TeleradiologyMarket – 2020-2024
15.2.1 PACS & TeleradiologyCOVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
15.2.2 PACS & TeleradiologyCOVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

16 PPE Gowns COVID-19 Pandemic Mitigation Market – 2020-2024.
16.1 Pandemic PPE Gowns Market Background.
16.1.1 Introduction and Findings.
16.1.2 PPE Gowns Market: Conclusions
16.1.3 PPE Gowns: Business Opportunities.
16.2 Global COVID-19 Pandemic Mitigation: PPE Gowns Market – 2020-2024
16.2.1 PPE Gowns COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
16.2.2 PPE Gowns COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

17 Gloves COVID-19 Pandemic Mitigation Market – 2020-2024.
17.1 COVID-19 Gloves Market Background
17.1.1 Introduction and Findings.
17.1.2 Gloves Market: Conclusions
17.1.3 Gloves: Business Opportunities.
17.2 Global COVID-19 Pandemic Mitigation: Gloves Market – 2020-2024
17.2.1 Gloves COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
17.2.2 Gloves COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

18 Face Masks COVID-19 Pandemic Mitigation Market – 2020-2024.
18.1 Medical Face Masks Market Background.
18.1.1 Introduction and Findings.
18.1.2 N95 Masks Vs. Surgical Mask
18.1.3 Face Masks Precautions
18.1.4 Face Masks Market: Conclusions
18.1.5 Face Masks: Business Opportunities.
18.1.6 Key Vendors
18.2 Global COVID-19 Pandemic Mitigation: Face Masks Market – 2020-2024
18.2.1 Face Masks COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
18.2.2 Face Masks COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

19 Medical Face Shields COVID-19 Pandemic Mitigation Market – 2020-2024
19.1 Medical Face Shields Market Background.
19.1.1 Introduction and Findings.
19.1.2 Face Shields Standards
19.2 Global COVID-19 Pandemic Mitigation: Medical Face Shields Market – 2020-2024.
19.2.1 Medical Face Shields COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
19.2.2 Medical Face Shields COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

20 Eye Protection COVID-19 Pandemic Mitigation Market – 2020-2024
20.1 Pandemic Eye Protection Market Background.
20.1.1 Introduction and Findings.
20.1.2 Key Vendors
20.2 Global COVID-19 Pandemic Mitigation: Eye Protection Market – 2020-2024.
20.2.1 Eye Protection COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
20.2.2 Eye Protection COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

21 PPE Sterilization: Systems & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024.
21.1 Global COVID-19 Pandemic Mitigation: PPE Sterilization: Systems & Consumables Market – 2020-2024
21.1.1 PPE Sterilization: Systems & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
21.1.2 PPE Sterilization: Systems & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

22 Hand & Surface Sanitizers COVID-19 Pandemic Mitigation Market – 2020-2024
22.1 Hand & Surface Sanitizers Market Background.
22.2 Global COVID-19 Pandemic Mitigation: Hand & Surface Sanitizers Market – 2020-2024
22.2.1 Hand & Surface Sanitizers COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
22.2.2 Hand & Surface Sanitizers COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

23 Decontamination COVID-19 Pandemic Mitigation Market – 2020-2024
23.1 Decontamination Market Background.
23.1.1 Introduction.
23.1.2 Definitions
23.1.3 Timing and Location Of Cleaning And Disinfection Of Surfaces
23.1.4 Hard (Non-porous) Surfaces
23.1.5 Soft (Porous) Surfaces
23.1.6 Electronics
23.1.7 Linens, Clothing, and Other Items That Go in the Laundry
23.1.8 Risk of Exposure
23.1.9 Considerations for Employers.
23.1.10 Decontamination Market: Conclusions
23.2 Global COVID-19 Pandemic Mitigation: Decontamination Market – 2020-2024
23.2.1 Decontamination COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
23.2.2 Decontamination COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

24 Other Personal Protection Gear COVID-19 Pandemic Mitigation Market – 2020-2024
24.1 Global COVID-19 Pandemic Mitigation: Other Personal Protection Gear Market – 2020-2024
24.1.1 Other Personal Protection Gear COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
24.1.2 Other Personal Protection Gear COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

25 AI, Big Data & Deep Learning COVID-19 Pandemic Mitigation Market – 2020-2024
25.1 Pandemic AI, Big Data & Deep Learning Market Background.
25.1.1 Introduction and Findings.
25.1.2 AI Based Early Warnings and Alerts.
25.1.3 Tracking and Prediction.
25.1.4 Data Dashboards.
25.1.5 Diagnosis and Prognosis
25.1.6 COVID-19 Treatments Optimization.
25.1.7 COVID-19 Pandemic Social Control.
25.1.8 Pandemic Outbreak Forecasting
25.1.9 AI, Big-Data and Deep Learning Assisted CT Imaging
25.1.10 AI, Big-Data and Deep-Learning Assisted COVID-19 Treatment
25.1.11 COVID-19: AI Assisted X-rays Imaging
25.1.12 COVID-19 AI, Big Data & Deep Learning
25.1.13 AI Assisted Pandemic Symptoms Analysis
25.1.14 AI, Big Data & Deep Learning Market: Conclusions
25.1.15 AI, Big Data & Deep Learning: Business Opportunities.
25.1.16 Key Vendors
25.2 Global COVID-19 Pandemic Mitigation: AI, Big Data & Deep Learning Market – 2020-2024
25.2.1 AI, Big Data & Deep Learning COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
25.2.2 AI, Big Data & Deep Learning COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

26 Homecare IT COVID-19 Pandemic Mitigation Market – 2020-2024.
26.1 Pandemic Homecare IT Market Background.
26.1.1 Introduction and Findings.
26.1.2 Homecare IT Market: Conclusions.
26.1.3 Homecare IT: Business Opportunities.
26.1.4 Key Vendors
26.2 Global COVID-19 Pandemic Mitigation: Homecare IT Market – 2020-2024
26.2.1 Homecare IT COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
26.2.2 Homecare IT COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

27 Geo-Surveillance Systems & Services COVID-19 Pandemic Mitigation Market – 2020-2024.
27.1 Pandemic Geo-Surveillance Systems & Services Market Background
27.1.1 Introduction and Findings.
27.1.2 MIT “Private Kit”
27.1.3 The UK NHS COVID-19 App
27.1.4 Companies Making Cell Location Tracking Technology
27.2 Global COVID-19 Pandemic Mitigation: Geo-Surveillance Systems & Services Market – 2020-2024
27.2.1 Geo-Surveillance Systems & Services COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
27.2.2 Geo-Surveillance Systems & Services COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

28 E-Health COVID-19 Pandemic Mitigation Market – 2020-2024.
28.1 Pandemic E-Health Market Background.
28.1.1 Introduction and Findings.
28.1.2 E-Health Market: Conclusions
28.1.3 E-Health: Business Opportunities.
28.1.4 Key Vendors
28.2 Global COVID-19 Pandemic Mitigation: E-Health Market – 2020-2024.
28.2.1 E-Health COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
28.2.2 E-Health COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

29 Blockchain Technologies COVID-19 Pandemic Mitigation Market – 2020-2024
29.1 Pandemic Blockchain Technologies Market Background.
29.1.1 Introduction and Findings.
29.1.2 Blockchain in Healthcare
29.1.3 Blockchain Applications.
29.1.4 Blockchain Technologies Market: Conclusions
29.1.5 Blockchain Technologies: Business Opportunities.
29.1.6 Key Vendors
29.2 Global COVID-19 Pandemic Mitigation: Blockchain Technologies Market – 2020-2024
29.2.1 Blockchain Technologies COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
29.2.2 Blockchain Technologies COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

30 Other ICT COVID-19 Pandemic Mitigation Market – 2020-2024.
30.1 Other Pandemics ICT Market Background.
30.1.1 Introduction and Findings.
30.1.2 Other ICT Market: Conclusions.
30.1.3 Other ICT: Business Opportunities
30.1.4 Vendors
30.2 Global COVID-19 Pandemic Mitigation: Other ICT Market – 2020-2024
30.2.1 Other ICT COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
30.2.2 Other ICT COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

31 Noninvasive Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024
31.1 Non-Invasive Ventilators Market Background.
31.1.1 Introduction and Findings.
31.1.2 The U.S. HHS Procurement Contracts On Non-Invasive Ventilators With Ten Vendors
31.1.3 Helmet-Based Non-invasive Ventilators
31.1.4 Non-invasive Ventilators Market: Conclusions
31.1.5 Business Opportunities.
31.1.6 Non-invasive Ventilators: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Barriers to Substitution.
31.1.7 Key Vendors
31.2 Global COVID-19 Pandemic Mitigation: Noninvasive Ventilators Market – 2020-2024
31.2.1 Noninvasive Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
31.2.2 Noninvasive Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

32 Invasive Mechanical Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024
32.1 Invasive Mechanical Ventilators Market Background.
32.1.1 Introduction and Findings.
32.1.2 Challenges of Traditional Mechanical Ventilation Devices
32.1.2.1 Difficult To Expand Capacity And Limited Portability.
32.1.2.2 Complex and Time Consuming To Administer Care.
32.1.2.3 Difficult To Switch Between Therapies.
32.1.3 Invasive Mechanical Ventilators Market: Conclusions
32.1.4 Invasive Mechanical Ventilators: Business Opportunities.
32.1.5 Invasive Mechanical Ventilators: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Barriers to Substitution.
32.1.6 Key Vendors
32.2 Global COVID-19 Pandemic Mitigation: Invasive Mechanical Ventilators Market – 2020-2024
32.2.1 Invasive Mechanical Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
32.2.2 Invasive Mechanical Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

33 Next Generation Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024
33.1 Next Generation Ventilators Market Background.
33.1.1 Introduction and Findings.
33.1.2 Next Generation Ventilators Market: Conclusions
33.1.3 Next Generation Ventilators: Business Opportunities.
33.1.4 Next Generation Ventilators: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Barriers to Substitution.
33.2 Global COVID-19 Pandemic Mitigation: Next Generation Ventilators Market – 2020-2024
33.2.1 Next Generation Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
33.2.2 Next Generation Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

34 Homecare “ICU” (Equipment, Software, Services) COVID-19 Pandemic Mitigation Market – 2020-2024.
34.1 COVID-19 Homecare “ICU” (Equipment, Software, Services) Market Background.
34.1.1 Introduction and Findings.
34.1.2 WHO Protocol For COVID-19 Homecare
34.1.3 Homecare Market: Conclusions.
34.1.4 Homecare Business Opportunities
34.1.5 Homecare: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Barriers to Substitution.
34.1.6 Key Vendors
34.2 Global COVID-19 Pandemic Mitigation: Homecare “ICU” (Equipment, Software, Services) Market – 2020-2024
34.2.1 Homecare “ICU” (Equipment, Software, Services) COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
34.2.2 Homecare “ICU” (Equipment, Software, Services) COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.
34.3 Portable Ventilators Market Background.
34.3.1 Introduction and Findings.
34.3.2 Portable Ventilators Market: Conclusions
34.3.3 Key Vendors
34.4 Global COVID-19 Pandemic Mitigation: Mobile Ventilators Market – 2020-2024.
34.4.1 Mobile Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
34.4.2 Mobile Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

35 Surge Capacity Hospitals COVID-19 Pandemic Mitigation Market – 2020-2024
35.1 Surge Capacity Hospitals Market Background.
35.1.1 Introduction and Findings.
35.1.2 Surge Capacity Hospitals Market: Conclusions
35.2 Global COVID-19 Pandemic Mitigation: Surge Capacity Hospitals Market – 2020-2024
35.2.1 Surge Capacity Hospitals COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
35.2.2 Surge Capacity Hospitals COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

36 Kidney Dialysis COVID-19 Pandemic Mitigation Market – 2020-2024
36.1 Kidney Dialysis Systems Market Background.
36.1.1 Introduction and Findings.
36.1.2 Kidney Dialysis Systems Market: Conclusions
36.1.3 Kidney Dialysis Systems: Business Opportunities.
36.1.4 Key Vendors
36.2 Global COVID-19 Pandemic Mitigation: Kidney Dialysis Market – 2020-2024
36.2.1 Kidney DialysisCOVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
36.2.2 Kidney DialysisCOVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

37 Extracorporeal Membrane Oxygenation Procedures COVID-19 Pandemic Mitigation Market – 2020-2024.
37.1 Extracorporeal Membrane Oxygenation Procedures Market Background.
37.1.1 Introduction and Findings.
37.1.2 The FDA Extracorporeal Membrane Oxygenation (ECMO) Policy
37.1.3 Extracorporeal Membrane Oxygenation Procedures Market: Conclusions
37.1.4 Extracorporeal Membrane Oxygenation Procedures: Business Opportunities.
37.1.5 Key Vendors
37.2 Global COVID-19 Pandemic Mitigation: Extracorporeal Membrane Oxygenation Procedures Market – 2020-2024
37.2.1 Extracorporeal Membrane Oxygenation Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
37.2.2 Extracorporeal Membrane Oxygenation Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

38 Other Intensive Care Modalities COVID-19 Pandemic Mitigation Market – 2020-2024
38.1 Other Intensive Care Modalities Market Background.
38.1.1 Introduction and Findings.
38.1.2 Other Intensive Care Modalities Market: Conclusions
38.2 Global COVID-19 Pandemic Mitigation: Other Intensive Care Modalities Market – 2020-2024
38.2.1 Other Intensive Care Modalities COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
38.2.2 Other Intensive Care Modalities COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

39 Gowns Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024
39.1 PPE Gowns Manufacturing Plants Market Background.
39.1.1 Introduction and Findings.
39.1.2 Gowns Manufacturing Plants Market: Conclusions
39.1.3 Gowns Manufacturing Plants: Business Opportunities.
39.2 Global COVID-19 Pandemic Mitigation: Gowns Manufacturing Plants Market – 2020-2024
39.2.1 Gowns Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
39.2.2 Gowns Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

40 Gloves Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024
40.1 Medical PPE Gloves Manufacturing Plants Market Background
40.1.1 Introduction and Findings.
40.1.2 Medical PPE Gloves Manufacturing Plants Market: Conclusions
40.1.3 Medical PPE Gloves Manufacturing Plants: Business Opportunities
40.2 Global COVID-19 Pandemic Mitigation: Gloves Manufacturing Plants Market – 2020-2024
40.2.1 Gloves Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
40.2.2 Gloves Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

41 Face Masks Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024
41.1 Face Masks Manufacturing Plants Market Background.
41.1.1 Introduction and Findings.
41.1.2 N95 Respirators Manufacturing.
41.1.3 Face Masks Manufacturing Plants Market: Conclusions
41.1.4 Face Masks Manufacturing Plants: Business Opportunities.
41.1.5 Key Vendors
41.2 Global COVID-19 Pandemic Mitigation: Face Masks Manufacturing Plants Market – 2020-2024
41.2.1 Face Masks Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
41.2.2 Face Masks Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

42 Face Shields Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024
42.1 Face Shields Manufacturing Plants Market Background.
42.1.1 Introduction and Findings.
42.2 Global COVID-19 Pandemic Mitigation: Face Shields Manufacturing Plants Market – 2020-2024
42.2.1 Face Shields Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
42.2.2 Face Shields Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

43 Serologic Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024.
43.1 Serologic Test Kits Manufacturing Plants Market Background.
43.1.1 Introduction and Findings.
43.1.2 Serologic Test Kits Manufacturing Plants Market: Conclusions
43.2 Global COVID-19 Pandemic Mitigation: Serologic Test Kits Manufacturing Plants Market – 2020-2024
43.2.1 Serologic Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
43.2.2 Serologic Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

44 Melt-Blown PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024.
44.1 Melt-Blown PPE Fabric Manufacturing Plants Market Background
44.1.1 Introduction and Findings.
44.1.2 Melt-Blown PPE Fabric. Manufacturing Plants Market: Conclusions
44.2 Global COVID-19 Pandemic Mitigation: Melt-Blown PPE Fabric Manufacturing Plants Market – 2020-2024
44.2.1 Melt-Blown PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
44.2.2 Melt-Blown PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

45 Spun-Bond PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024.
45.1 Spun-Bond PPE Fabric Manufacturing Plants Market Background
45.1.1 Introduction and Findings.
45.1.2 Spun-Bond PPE Fabric Manufacturing Plants Market: Conclusions
45.2 Global COVID-19 Pandemic Mitigation: Spun-Bond PPE Fabric Manufacturing Plants Market – 2020-2024
45.2.1 Spun-Bond PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
45.2.2 Spun-Bond PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

46 Self-collection PCR Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024.
46.1 Market Background.
46.2 Global COVID-19 Pandemic Mitigation: Self-collection PCR Test Kits Manufacturing Plants Market – 2020-2024.
46.2.1 Self-collection PCR Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.
46.2.2 Self-collection PCR Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.

47 Ventilators Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024
47.1 Ventilators Manufacturing Plants Market Background.
47.1.1 Introduction and Findings.
47.1.2 Ventilators Manufacturing Plants Market: Conclusions
47.2 Global COVID-19 Pandemic Mitigation: Ventilators Manufacturing Plants Market – 2020-2024
47.2.1 Ventilators Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
47.2.2 Ventilators Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

48 PCR Reagents Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024.
48.1 Global COVID-19 Pandemic Mitigation: PCR Reagents Manufacturing Plants Market – 2020-2024
48.1.1 PCR Reagents Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
48.1.2 PCR Reagents Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

49 PCR Systems Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024
49.1 Global COVID-19 Pandemic Mitigation: PCR Systems Manufacturing Plants Market – 2020-2024
49.1.1 PCR Systems Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
49.1.2 PCR Systems Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

50 Nose & Mouth Swabs Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024.
50.1 Nose & Mouth Swabs Manufacturing Plants Market Background
50.1.1 Introduction and Findings.
50.1.2 Swabs Manufacturing Plants Market: Conclusions
50.1.3 Swabs Manufacturing Plants: Business Opportunities.
50.2 Global COVID-19 Pandemic Mitigation: Nose & Mouth Swabs Manufacturing Plants Market – 2020-2024
50.2.1 Nose & Mouth Swabs Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
50.2.2 Nose & Mouth Swabs Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

51 Medical Glass & Other Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024.
51.1 Global COVID-19 Pandemic Mitigation: Medical Glass & Other Manufacturing Plants Market – 2020-2024
51.1.1 Medical Glass & Other Manufacturing PlantsCOVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
51.1.2 Medical Glass & Other Manufacturing PlantsCOVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

52 R&D Equipment & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024
52.1 Global COVID-19 Pandemic Mitigation: R&D Equipment & Consumables Market – 2020-2024
52.1.1 R&D Equipment & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
52.1.2 R&D Equipment & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

53 Medical Glass and Other Products & Services COVID-19 Pandemic Mitigation Market – 2020-2024.
53.1 Medical Glass and Other Products & Services Market Background
53.1.1 Medical Glass Introduction and Findings
53.1.2 Medical Glass Market: Conclusions.
53.1.3 Key Medical Glass Vendors.
53.2 Global COVID-19 Pandemic Mitigation: Medical Glass and Other Products & Services Market – 2020-2024.
53.2.1 Medical Glass and Other Products & Services COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A
53.2.2 Medical Glass and Other Products & Services COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B

COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 3

VERTICAL MARKETS.

1 Hospitals and Surge Hospitals COVID-19 Pandemic Mitigation Market – 2020-2024
1.1 Market Background
1.2 Global COVID-19 Pandemic Mitigation: Hospitals and Surge Hospitals Market – 2020-2024.
1.2.1 COVID-19 Pandemic Mitigation Hospitals and Surge Hospitals Market: Scenario A
1.2.2 COVID-19 Pandemic Mitigation Hospitals and Surge Hospitals Market: Scenario B
1.2.3 Hospitals and Surge Hospitals Market: Scenarios Comparison

2 Clinical Labs COVID-19 Pandemic Mitigation Market – 2020-2024.
2.1 Market Background
2.2 Global COVID-19 Pandemic Mitigation: Clinical Labs Market – 2020-2024
2.2.1 COVID-19 Pandemic Mitigation Clinical Labs Market: Scenario A.
2.2.2 COVID-19 Pandemic Mitigation Clinical Labs Market: Scenario B.
2.2.3 Clinical Labs Market: Scenarios Comparison

3 Clinics COVID-19 Pandemic Mitigation Market – 2020-2024
3.1 Market Background
3.2 Global COVID-19 Pandemic Mitigation: Clinics Market – 2020-2024
3.2.1 COVID-19 Pandemic Mitigation Clinics Market: Scenario A.
3.2.2 COVID-19 Pandemic Mitigation Clinics Market: Scenario B.
3.2.3 Clinics Market: Scenarios Comparison

4 Emergency Medical Services (EMS) COVID-19 Pandemic Mitigation Market – 2020-2024
4.1 Market Background
4.2 Global COVID-19 Pandemic Mitigation: Emergency Medical Services (EMS) Market – 2020-2024
4.2.1 COVID-19 Pandemic Mitigation Emergency Medical Services (EMS) Market: Scenario A
4.2.2 COVID-19 Pandemic Mitigation Emergency Medical Services (EMS) Market: Scenario B
4.2.3 Emergency Medical Services Market: Scenarios Comparison.

5 Homecare & Nursing Homes COVID-19 Pandemic Mitigation Market – 2020-2024
5.1 Market Background
5.2 Global COVID-19 Pandemic Mitigation: Homecare & Nursing Homes Market – 2020-2024.
5.2.1 COVID-19 Pandemic Mitigation Homecare & Nursing Homes Market: Scenario A.
5.2.2 COVID-19 Pandemic Mitigation Homecare & Nursing Homes Market: Scenario B.
5.2.3 Homecare & Nursing Homes Market: Scenarios Comparison.

6 Research Bodies COVID-19 Pandemic Mitigation Market – 2020-2024.
6.1 Market Background
6.2 Global COVID-19 Pandemic Mitigation: Research Bodies Market – 2020-2024
6.2.1 COVID-19 Pandemic Mitigation Research Bodies Market: Scenario A
6.2.2 COVID-19 Pandemic Mitigation Research Bodies Market: Scenario B
6.2.3 Research Bodies Market: Scenarios Comparison

REGIONAL MARKETS

7 North America COVID-19 Pandemic Mitigation Market – 2020-2024
7.1 North America Vertical Markets – 2020-2024.
7.1.1 North America COVID-19 Pandemic Mitigation Market: Scenario A
7.1.2 North America COVID-19 Pandemic Mitigation Market: Scenario B
7.1.3 Scenarios Comparison.
7.2 North America COVID-19 Pandemic Mitigation Market by Revenue Source – 2020-2024.
7.2.1 North America COVID-19 Pandemic Mitigation Products & Services Market: Scenario A
7.2.2 North America COVID-19 Pandemic Mitigation Products & Services Market: Scenario B

8 Europe COVID-19 Pandemic Mitigation Market – 2020-2024.
8.1 Europe Vertical Markets – 2020-2024
8.1.1 Europe COVID-19 Pandemic Mitigation Market: Scenario A
8.1.2 Europe COVID-19 Pandemic Mitigation Market: Scenario B
8.1.3 Scenarios Comparison.
8.2 Europe COVID-19 Market by Revenue Source – 2020-2024
8.2.1 Europe COVID-19 Pandemic Mitigation Products & Services Market: Scenario A
8.2.2 Europe COVID-19 Pandemic Mitigation Products & Services Market: Scenario B

9 Asia-Pacific COVID-19 Pandemic Mitigation Market – 2020-2024.
9.1 Asia-Pacific Vertical Markets – 2020-2024
9.1.1 Asia-Pacific COVID-19 Pandemic Mitigation Market: Scenario A
9.1.2 Asia-Pacific COVID-19 Pandemic Mitigation Market: Scenario B
9.1.3 Scenarios Comparison.
9.2 Asia-Pacific COVID-19 Market by Revenue Source – 2020-2024
9.2.1 Asia-Pacific COVID-19 Pandemic Mitigation Products & Services Market: Scenario A
9.2.2 Asia-Pacific COVID-19 Pandemic Mitigation Products & Services Market: Scenario B

10 MEA & Latin America COVID-19 Pandemic Mitigation Market – 2020-2024
10.1 MEA & Latin America Vertical Markets – 2020-2024.
10.1.1 MEA & Latin America COVID-19 Pandemic Mitigation Market: Scenario A
10.1.2 MEA & Latin America COVID-19 Pandemic Mitigation Market: Scenario B
10.1.3 Scenarios Comparison.
10.2 MEA & Latin America COVID-19 Market by Revenue Source – 2020-2024
10.2.1 MEA & Latin America COVID-19 Pandemic Mitigation Products & Services Market: Scenario A.
10.2.2 MEA & Latin America COVID-19 Pandemic Mitigation Products & Services Market: Scenario B.

NATIONAL MARKETS.

11 USA COVID-19 Pandemic Mitigation Market – 2020-2024.
11.1 Market Background
11.2 USA COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024

12 Canada COVID-19 Pandemic Mitigation Market – 2020-2024.
12.1 Market Background
12.2 Canada COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024

13 U.K. COVID-19 Pandemic Mitigation Market – 2020-2024.
13.1 Market Background
13.2 U.K. COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024

14 Germany COVID-19 Pandemic Mitigation Market – 2020-2024.
14.1 Market Background
14.2 Germany COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024

15 France COVID-19 Pandemic Mitigation Market – 2020-2024.
15.1 Market Background
15.2 France COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024

16 Italy COVID-19 Pandemic Mitigation Market – 2020-2024.
16.1 Market Background
16.2 Italy COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024

17 Rest of Europe COVID-19 Pandemic Mitigation Market – 2020-2024

18 India COVID-19 Pandemic Mitigation Market – 2020-2024.
18.1 Market Background
18.2 India COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024

19 China COVID-19 Pandemic Mitigation Market – 2020-2024
19.1 Market Background.
19.2 China COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024

20 South Korea COVID-19 Pandemic Mitigation Market – 2020-2024
20.1 Market Background.
20.2 South Korea COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024.

21 Japan COVID-19 Pandemic Mitigation Market – 2020-2024
21.1 Market Background.
21.2 Japan COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024

22 Rest of Asia-Pacific COVID-19 Pandemic Mitigation Market – 2020-2024

23 ROW COVID-19 Pandemic Mitigation Market – 2020-2024

COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 4

MAJOR VENDORS

COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 5

APPENDICES

1 Appendix 1: Differences & Similarities Between Common Flu and Coronavirus
1.1 Similarities:
1.2 Differences

2 Appendix 2: Coronavirus Personal Protective Equipment (PPE) for Healthcare Personnel
2.1 Introduction
2.2 Conclusions
2.3 Findings Summary.
2.4 Background
2.4.1 Description of the Condition
2.4.2 Description of the Intervention
2.4.3 How the Intervention Might Work.
2.4.4 Why it Is Important To Do This Review
2.4.5 Summary

3 Appendix 3: CDC Strategies for Optimizing the Supply of Eye Protection
3.1 Introduction
3.1.1 Contingency Capacity Strategies.
3.1.2 Extended Use Of Eye Protection.
3.1.3 Crisis Capacity Strategies
3.1.4 Selected Options for Reprocessing Eye Protection.

4 Appendix 4: CDC Strategies for Optimizing the Supply of Isolation Gowns
4.1 Purpose
4.2 Conventional Capacity Strategies
4.3 Contingency Capacity Strategies.
4.4 Crisis Capacity Strategies
4.5 Extended Use of Isolation Gowns
4.5.1 Re-use of Cloth Isolation Gowns.
4.5.2 Prioritize Gowns
4.5.3 When No Gowns Are Available

5 Appendix 5: CDC Strategy for Optimizing the Supply of Facemasks
5.1 Purpose
5.2 Conventional Capacity Strategies
5.3 Contingency Capacity Strategies.
5.4 When No Facemasks Are Available, Options Include

6 Appendix 6: CDC Strategies for Optimizing the Supply of N95 Respirators

7 Appendix 7: CDC Adult Vaccine Price List
7.1 CDC Vaccine 2020-2021 Price List.
7.2 CDC Influenza Vaccine 2020-2021 Price List

8 Appendix 8: The CDC COVID-19 Bio-Safety Guidelines
8.1 The CDC Safety Practices for Critical Infrastructure Workers Exposed to a Person with Suspected or Confirmed COVID-19
8.2 Use of Cloth Face Coverings.
8.3 The Emergency Medical Services Guidance
8.4 Recommendations for 911 PSAPs
8.4.1 Modified Caller Queries
8.5 EMS Clinicians and Medical First Responders
8.5.1 Patient assessment
8.6 Recommended Personal Protective Equipment.
8.7 Precautions for Aerosol-Generating Procedures
8.8 EMS Transport of a PUI or Patient with Confirmed COVID-19 to a Healthcare Facility.
8.9 Documentation Of Patient Care
8.10 Cleaning EMS Transport Vehicles after Transporting a PUI or Patient with Confirmed COVID-19
8.11 Measures by EMS Clinicians After Caring for a PUI or Patient with Confirmed COVID-19
8.12 EMS Employer Responsibilities

9 Appendix 9: The 2020 Global Desperation to Protect Medical Workers

10 Appendix 10: Disinfection Procedures for COVID-19.
10.1 Disinfection for Floor and Walls
10.2 Disinfection of Object Surfaces.
10.3 Air Disinfection.
10.4 Disposal of Fecal Matter and Sewage
10.5 Disposal Procedures for Spills of COVID-19 Patient Blood/Fluids

11 Appendix 11: Breakdown of the COVID-19 USA Medical Services Stimulus April 2020
11.1 Public Health and Social Services Emergency Fund – March 2020
11.2 For Advance Construction, Manufacture, And Purchase Of Vaccines And Therapeutic Delivery.
11.3 Telehealth, Poison Control Centers, And The Ryan White HIV/AIDS Program
11.4 National Institutes of Health
11.5 Substance Abuse and Mental Health Services Administration
11.6 Administration for Children and Families
11.7 Veterans Health Administration

12 Appendix 12: European Preparedness Against Emerging Epidemics

13 Appendix 13: Development and Regulation by the CDC and FDA Diagnostic Testing for COVID-19.
13.1 Introduction
13.2 Diagnostic Tests.
13.1.1 IVD Tests
13.1.2 LDT Tests
13.1.3 How are IVD Tests Regulated?
13.1.4 How are LDTs Regulated?.
13.1.5 What is CLIA and How Is It Involved in LDT Regulation?
13.1.6 How are IVDs Regulated by the FDA During an Emergency Such as the Outbreak of COVID-19?
13.1.7 How Does the Emergency Use Authority Apply to LDTs if They Are Generally Exempted from Premarket Requirements?
13.1.8 How Does the CDC’s COVID-19 Diagnostic Test Work?.
13.1.9 What Type of IVD is the CDC’s Test and Who May Carry it Out?
13.1.10 What Is the Role of the Commercial Manufacturer IDT in the Development and Distribution of the CDC’s Test Kit?
13.1.11 What Quality Problems Did the CDC’s Test Experience on Rollout to the State and Local Public Health Laboratories?
13.1.12 What Steps did the FDA Take to Expand Testing Capacity in Response to the Problems with the CDC’s Test?

14 Appendix 14: The U.S. Defense Production Act: Example FEMA COVID-19 Supply Chain Stabilization.

15 Appendix 15: The Global Research Collaboration for Infectious Disease Preparedness (GLOPID-R).

16 Appendix 16: Comparing Clinical COVID-19 Data by Nation.
16.1 Introduction
16.2 Counting Deaths Protocols.
16.3 National Death Rates
16.4 National Political Factors.
16.5 National Testing Protocols
16.6 Conclusions: Comparisons are Difficult.

17 Appendix 17: Home Healthcare IT.
17.1 Introduction
17.2 Online Bots
17.3 Home Telehealth.
17.4 Telemedicine Billing
17.5 Commercial Insurance.

18 Appendix 18: The Difference between PCR and Antibody Tests

19 Appendix 19: COVID-19 Pandemic Global Economic Effects- 2020-2021
19.1 Introduction
19.2 Economic Effects
19.3 USA
19.4 Europe.
19.5 The UK
19.6 Japan
19.7 China
19.8 The IMF
19.9 The World Bank
19.10 Emerging Markets
19.11 Other Sectors.

20 Appendix 20: COVID-19 Tests
20.1 COVID-19 Tests Sensitivity and Specificity
20.2 RT-PCR tests.
20.3 Antibody Tests
20.4 Other Diagnostic Options.
20.5 Procurement of Test Kits and Consumables.
20.6 Annex A: Test Kit Options from WHO Diagnostics Consortium.

21 Appendix 21: Rapid Communication on the Role of the GeneXpert® Platform for Rapid Molecular Testing for SARS-CoV-2 in the WHO European Region.

22 Appendix 22: Abbreviations

23 Appendix 23: Glossary.

24 Appendix 24: Bibliography.

25 Research Methodology.
25.1 Scope
25.2 Research Methodology

26 Disclaimer & Copyright.

Note: Product cover images may vary from those shown
3 of 3
  • 3M Company
  • 3Scan
  • Abbott
  • AbCellera
  • Advenio Technosys
  • Agfa Healthcare
  • Agilent Technologies
  • AiCure
  • Aindra
  • Allscripts Healthcare Solutions
  • Amara Health Analytics
  • Amazon
  • analyticsMD
  • Apixio
  • Apple
  • Arterys Inc
  • Atlas Wearables
  • Atomwise
  • Avalon Nutrition VITL
  • Babylon Health
  • Bay Labs
  • Behold.ai
  • benevolent.ai
  • BIOBEATS
  • BlueDot
  • Bollé Safety
  • Bullard
  • Buoy Health
  • Care Angel Wearables QorQL
  • Careskore
  • Clinithink
  • Cloud Pharmaceuticals
  • CloudMedx
  • CureMetrix Mental health Ginger.io
  • Cyrcadia
  • Deep 6 AI
  • Deep Genomics
  • Dell Technologies Inc.
  • Delta Plus Group
  • Desktop Genetics Virtual mate Ada Health
  • DreaMed Diabetes
  • Dupont
  • EaglEyeMed
  • Eli Lilly
  • Encon Safety Products
  • Enlitic
  • EnsoData
  • Entopsis
  • Envisagenics Research iCarbonX
  • ERB Industries Inc.
  • Ergodyne
  • Essilor of America
  • Flashback Technologies
  • Flow Health
  • Ford
  • Freenome
  • Frequency Therapeutics Inc.
  • Fujifilm Holdings Corporation
  • Gateway Safety Inc.
  • GE Healthcare
  • General Electric
  • General Motors
  • General Vision
  • Gentex Corporation
  • Gibco
  • Gilead Sciences
  • Globavir Biosciences
  • Google
  • Healint
  • Health Fidelity
  • HealthNextGen
  • HexArmor
  • Hindsait
  • Honeywell Safety Products
  • IBM
  • Imagen Technologies
  • Imagia Cybernetics
  • Infermedica
  • Infervision
  • Inovio Pharmaceuticals
  • Inside DNA
  • InSilico Medicine
  • Intel Corporation
  • Intendu
  • Invitrogen
  • Ion Torrent
  • Ironwear
  • Johnson & Johnson (Janssen)
  • Jvion
  • Kapa Biosystems
  • Keen Eye Technologies
  • Kimberly-Clark Professional
  • Koninklijke Philips NV
  • Lexmark International Inc.
  • LifeGraph
  • Lucina Health
  • Lumiata
  • Lunit
  • Lytics
  • Magnea
  • Maxim Biotech
  • Maxwell MRI
  • McKesson Corporation
  • MCR Safety
  • Medal
  • Medalogix
  • Medasense
  • MedAware
  • Medtronic
  • MedWhat
  • MedyMatch
  • Merck
  • Metabiota
  • Micron Technology
  • Microsoft Corporation
  • Mindshare Medical
  • Moderna
  • Morpheo
  • Niramai Health Analytix
  • Novarad Corporation
  • NuMedii
  • Numerate
  • Nuritas Pharma Turbine
  • Nvidia Corporation
  • Oncora Medical
  • Ovuline
  • PeerWell
  • Pfizer
  • Philips
  • Philips Healthcare
  • PhysIQ.
  • Precision Health Intelligence
  • Predible Health
  • Profility
  • Proscia
  • pulseData
  • Pyramex Safety
  • Qualaris Healthcare Solutions
  • Qualcomm Incorporated
  • Qualcomm Incorporated
  • Qure. Ai
  • Radians Inc.
  • Recursion Pharmaceuticals
  • Regeneron Pharmaceuticals
  • Roam Analytics   
  • Roche
  • RxPREDICT
  • Safety Optical Service
  • Samsung Electronics Co. Ltd
  • Sanofi
  • Saykara
  • Sellstrom Manufacturing Company (SureWerx)
  • Sense.ly
  • Sensory Inc.
  • Siemens
  • Sigma-Aldrich Corp.
  • Skymind Inc.
  • Thermo Fisher Scientific
  • Toshiba
  • Vir Biotechnology Inc.
  • VisionAid Inc.
  • WuXi Biologics
  • Xilinx Inc.
Note: Product cover images may vary from those shown
Adroll
adroll